Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BAY 86-5300 in Japanese Patients With Endometriosis
NCT01697111Phase 3Completed
- Sponsor
- Bayer
- Start
- Oct 2012
- Primary completion
- Mar 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ethinyl estradiol + drospirenone in endometriosis, sponsored by Bayer. Started Oct 2012; status: completed.
02
Drugs
ethinyl estradiol + drospirenone
03
Conditions
endometriosis
Beyond the preview
Go deeper on NCT01697111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01697111.